Walter R. Wilson

Walter R. Wilson's AcademicInfluence.com Rankings

Walter R. Wilson

Philosophy

#8083

World Rank

#11400

Historical Rank

Logic

#5115

World Rank

#6481

Historical Rank

philosophy Degrees

Walter R. Wilson

Biology

#10920

World Rank

#14284

Historical Rank

Immunology

#693

World Rank

#715

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Walter R. Wilson's Degrees

Doctorate Medicine Harvard University
PhD Immunology Stanford University

Why Is Walter R. Wilson Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Walter R. Wilson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Card (2007) (2635)
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association (2015) (1907)
Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. (2013) (1606)
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association (2004) (1523)
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association (2004) (1373)
Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. (2010) (947)
Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. (2012) (830)
Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. (1992) (682)
Diagnosis and management of infective endocarditis and its complications. (1998) (663)
Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. (2007) (660)
Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. (2013) (614)
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. (1997) (572)
Special Report Diagnosis and Therapy of Kawasaki Disease in Children (1993) (492)
Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. (1995) (489)
Prevention of bacterial endocarditis. (1983) (400)
Emboli in infective endocarditis: the prognostic value of echocardiography. (1991) (385)
Nonvalvular Cardiovascular Device–Related Infections (2003) (380)
Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. (2007) (366)
Guidelines for the Diagnosis of Rheumatic Fever: Jones Criteria, Updated 1992 Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, American Heart Association (1993) (335)
Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. (2005) (325)
A systematic review of population-based studies of infective endocarditis. (2007) (325)
Prevention of bacterial endocarditis: recommendations by the American Heart Association. (1998) (322)
Optimal testing parameters for blood cultures. (2004) (282)
Risk factor analysis of permanent pacemaker infection. (2007) (270)
Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. (2008) (263)
Vascular Graft Infections, Mycotic Aneurysms, and Endovascular Infections: A Scientific Statement From the American Heart Association (2016) (247)
Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. (1994) (240)
Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. (2010) (222)
Infective endocarditis caused by HACEK microorganisms. (1997) (222)
Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. (2007) (219)
Prosthetic valve endocarditis. (1975) (203)
Microbiological and clinical evaluation of the isolator lysis-centrifugation blood culture tube (1983) (198)
Influence of referral bias on the apparent clinical spectrum of infective endocarditis. (1990) (196)
Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota. (2010) (194)
An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. (1997) (189)
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease (2014) (161)
Unique features of infective endocarditis in childhood. (2002) (159)
Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group. (1998) (159)
Erythromycin: A Microbial and Clinical Perspective After 30 Years of Clinical Use (First of Two Parts)* (1985) (154)
Unique features of infective endocarditis in childhood. (2002) (153)
Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. (1984) (143)
Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. (2011) (143)
Incidence of Infective Endocarditis Caused by Viridans Group Streptococci Before and After Publication of the 2007 American Heart Association's Endocarditis Prevention Guidelines (2012) (143)
Risk factors for infective endocarditis. (1993) (140)
Clinical significance of Pseudallescheria boydii: a review of 10 years' experience. (1985) (138)
Anaerobic bacteremia: decreasing rate over a 15-year period. (1991) (137)
Prevention of bacterial endocarditis: recommendations by the American Heart Association. (1991) (137)
Analysis of 281,797 consecutive blood cultures performed over an eight-year period: trends in microorganisms isolated and the value of anaerobic culture of blood. (1997) (136)
Infective endocarditis. Olmsted County, Minnesota, 1950 through 1981. (1985) (134)
Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays (1991) (130)
Pulmonary Disease in the Immunocompromised Host (First of Two Parts) (1985) (125)
The Impact of Valve Surgery on 6-Month Mortality in Left-Sided Infective Endocarditis (2007) (124)
Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis. (2007) (121)
Candidemia from a urinary tract source: microbiological aspects and clinical significance. (1993) (121)
Anticoagulant Therapy and Central Nervous System Complications in Patients with Prosthetic Valve Endocarditis (1978) (120)
Nonvalvular cardiovascular device-related infections. (2004) (116)
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. (1997) (111)
Prosthetic vascular graft infection: a risk factor analysis using a case-control study. (2006) (109)
Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention (2010) (107)
Clinical practice. Infections of cardiovascular implantable electronic devices. (2012) (106)
Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia. (2006) (106)
Short-term therapy for streptococcal infective endocarditis. Combined intramuscular administration of penicillin and streptomycin. (1981) (102)
Valve Replacement in Patients with Active Infective Endocarditis (1978) (98)
Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin. (1987) (98)
Prospective risk assessment of bacteremia and other infectious complications in patients undergoing EUS-guided FNA. (2003) (97)
Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis (2020) (94)
Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT): Scoring System to Guide Use of Echocardiography in the Management of Staphylococcus aureus Bacteremia. (2015) (92)
Adverse effects of vancomycin administered in the perioperative period. (1986) (91)
Predictors of mortality in patients with cardiovascular implantable electronic device infections. (2013) (86)
Infectious complications of percutaneous vascular closure devices. (2005) (84)
Toxic shock syndrome, a newly recognized disease entity. Report of 11 cases. (1980) (83)
Cardiovascular Implantable Electronic Device Infection in Patients with Staphylococcus aureus Bacteremia (2010) (82)
Fungal sinusitis in healthy and immunocompromised individuals. (1984) (81)
Management of complications of infective endocarditis. (1982) (80)
Clinical Predictors of Cardiovascular Implantable Electronic Device‐Related Infective Endocarditis (2009) (79)
Tetracyclines, chloramphenicol, erythromycin, clindamycin, and metronidazole. (1991) (77)
A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Endorsed by the American Academy of Pediatrics (2004) (76)
Antimicrobial susceptibilities of species of viridans streptococci. (1979) (75)
Clinical Presentation, Risk Factors, and Outcomes of Hematogenous Prosthetic Joint Infection in Patients with Staphylococcus aureus Bacteremia. (2016) (74)
Open lung biopsy in immunocompromised patients. (1985) (73)
Pregnancy and postpartum infective endocarditis: a systematic review. (2014) (72)
Temporal trends in infective endocarditis epidemiology from 2007 to 2013 in Olmsted County, MN. (2015) (71)
Prospective study of bacteremia and complications With EUS FNA of rectal and perirectal lesions. (2007) (70)
Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections (2011) (70)
Medical versus surgical management of Staphylococcus aureus prosthetic valve endocarditis. (2006) (69)
Antimicrobial Susceptibility Patterns among Viridans Group Streptococcal Isolates from Infective Endocarditis Patients from 1971 to 1986 and 1994 to 2002 (2004) (65)
Incidence of Bacteremia in Adults Without Infection (1975) (63)
Prospective Evaluation of the Risk of Bacteremia Associated With Transesophageal Echocardiography (1991) (62)
Infective endocarditis--a 25 year overview of diagnosis and therapy. (1983) (62)
Erythromycin: a microbial and clinical perspective after 30 years of clinical use (1). (1985) (61)
Haemophilus endocarditis. Report of 14 patients. (1977) (60)
Incidence of Infective Endocarditis Due to Viridans Group Streptococci Before and After the 2007 American Heart Association's Prevention Guidelines: An Extended Evaluation of the Olmsted County, Minnesota, Population and Nationwide Inpatient Sample. (2015) (60)
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study (2021) (60)
Erythromycin: a microbial and clinical perspective after 30 years of clinical use (2). (1985) (60)
Molecular, serological, and clinical features of 16 consecutive cases of invasive streptococcal disease. Southeastern Minnesota Streptococcal Working Group. (1998) (57)
Rhino-Orbitocerebral Mucormycosis Caused by Apophysomyces elegans (2006) (57)
The role of valve surgery in infective endocarditis management: a systematic review of observational studies that included propensity score analysis. (2008) (56)
Treatment of streptococcal infective endocarditis. (1985) (55)
Vancomycin therapy for infective endocarditis. (1981) (54)
Cardiac valve replacement in congestive heart failure due to infective endocarditis. (1979) (54)
Prospective randomized comparison of mezlocillin therapy alone with combined ampicillin and gentamicin therapy for patients with cholangitis. (1989) (54)
Infective endocarditis due to penicillin-resistant viridans group streptococci. (2007) (53)
Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents. (1996) (53)
Fungal prosthetic valve endocarditis: Mayo Clinic experience with a clinicopathological analysis (2011) (52)
Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement From the American Heart Association (2021) (51)
Short-Term Intramuscular Therapy with Procaine Penicillin Plus Streptomycin for Infective Endocarditis due to Viridans Streptococci (1978) (51)
Pulmonary Disease in the Immunocompromised Host (Second of Two Parts) (1985) (51)
Symposium on infective endocarditis. III. Endocarditis due to gram-negative bacteria. Report of 56 cases. (1982) (48)
Periodontal Disease and Atherosclerotic Vascular Disease: Does the Evidence Support an Independent Association? A (2012) (48)
Outcomes in Patients With Cardiovascular Implantable Electronic Devices and Bacteremia Caused by Gram-Positive Cocci Other Than Staphylococcus Aureus (2010) (47)
In vitro and in vivo activity of ciprofloxacin against enterococci isolated from patients with infective endocarditis (1987) (46)
Lemierre syndrome variant: necrobacillosis associated with inferior vena cava thrombosis and pulmonary abscesses after trauma-induced leg abscess. (2003) (46)
The association between the timing of valve surgery and 6-month mortality in left-sided infective endocarditis (2008) (46)
The antimicrobial removal device. A microbiological and clinical evaluation. (1982) (45)
In vitro activity of BAL9141 against clinical isolates of gram-negative bacteria. (2004) (44)
Trends in Infective Endocarditis Incidence, Microbiology, and Valve Replacement in the United States From 2000 to 2011: The Devil Is in the Details. (2015) (44)
Clinical features and outcomes of cardiovascular implantable electronic device infections due to staphylococcal species. (2012) (42)
Outcomes in Patients With Cardiovascular Implantable Electronic Device Infection Managed With Chronic Antibiotic Suppression (2016) (41)
Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis (1990) (41)
Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis (1997) (40)
Comparison of ciprofloxacin and co-trimoxazole in the treatment of uncomplicated urinary tract infection in women. (1986) (39)
Clinical-histologic-microbiologic analysis of 419 lymph node biopsy specimens. (1986) (39)
Tetracyclines, chloramphenicol, erythromycin, and clindamycin. (1987) (38)
Predicting Risk of Endovascular Device Infection in Patients With Staphylococcus aureus Bacteremia (PREDICT-SAB) (2015) (37)
Synergy of penicillin and decreasing concentration of aminoglycosides against enterococci from patients with infective endocarditis (1980) (37)
Infective endocarditis caused by Actinobacillus actinomycetemcomitans: report of four cases. (1980) (36)
Prosthetic pulmonary valve and pulmonary conduit endocarditis: clinical, microbiological and echocardiographic features in adults. (2016) (36)
Treatment of infective endocarditis due to viridans streptococci, This statement was prepared by the ad hoc subcommittee on Treatment of Bacterial endocarditis of the American Heart Association Council on Cardiovascular Disease in the Young. (1981) (36)
Relative efficacies of broad-spectrum cephalosporins for treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis (1993) (35)
Antibiotic treatment of infective endocarditis due to viridans streptococci, enterococci, and other streptococci. (1998) (33)
Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci (1982) (33)
A summary of the update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. (2011) (32)
Experimental animal endocarditis. (1982) (32)
Clinical significance of postmortem cultures. (1972) (32)
Infective Endocarditis Involving the Pulmonary Valve. (2015) (32)
Long-Term Management of Kawasaki Disease : A Statement for Health Professionals From the Committee on Rheumatic Fever , Endocarditis , and Kawasaki Disease , Council on Cardiovascular Disease in the (2004) (31)
Lack of benefit of intravenous immune globulin in a murine model of group A streptococcal necrotizing fasciitis. (2000) (30)
Paraspinal abscess complicated by endocarditis following a facet joint injection ⋆ (2008) (30)
Antimicrobial therapy of experimental endocarditis caused by nutritionally variant viridans group streptococci (1986) (30)
Ketolide Treatment of Haemophilus influenzae Experimental Pneumonia (1999) (29)
Clinical presentation and outcomes of cardiovascular implantable electronic device infections in hemodialysis patients. (2014) (29)
Augmented Curation of Unstructured Clinical Notes from a Massive EHR System Reveals Specific Phenotypic Signature of Impending COVID-19 Diagnosis (2020) (27)
Cardiobacterium hominis endocarditis. Four cases with clinical and laboratory observations. (1978) (27)
Increased risk of prosthetic joint infection associated with esophago-gastro-duodenoscopy with biopsy (2013) (27)
General considerations in the diagnosis and treatment of infective endocarditis. (1982) (27)
Comparison of Dual β-Lactam therapy to penicillin-aminoglycoside combination in treatment of Enterococcus faecalis infective endocarditis. (2018) (27)
International experts' practice in the antibiotic therapy of infective endocarditis is not following the guidelines. (2017) (26)
Modifiers of symptomatic embolic risk in infective endocarditis. (2011) (25)
Treatment of penicillin-sensitive streptococcal infective endocarditis. (1982) (25)
Utility of cardiac computed tomography scanning in the diagnosis and pre-operative evaluation of patients with infective endocarditis (2018) (24)
Prosthetic valve endocarditis. (1982) (24)
Effective treatment of cephalosporin-rifampin combinations against cryptic methicillin-resistant beta-lactamase-producing coagulase-negative staphylococcal experimental endocarditis (1995) (24)
Infective endocarditis: therapeutic considerations. (1980) (23)
Penicillin therapy for treatment of experimental endocarditis caused by viridans streptococci in animals. (1985) (22)
Influence of gentamicin dose size on the efficacies of combinations of gentamicin and penicillin in experimental streptomycin-resistant enterococcal endocarditis (1982) (21)
Epidemiology, laboratory detection, and therapy of penicillin-resistant streptococcal infections. (1998) (21)
Conclusion about the association between valve surgery and mortality in an infective endocarditis cohort changed after adjusting for survivor bias. (2010) (21)
Group B streptococcal infective endocarditis. (1985) (20)
Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus (1988) (20)
Current Diagnosis & Treatment in Infectious Diseases (2001) (19)
Bacterial Brain Abscess: An Outline for Diagnosis and Management. (2021) (19)
Ciprofloxacin versus trimethoprim-sulfamethoxazole: treatment of community-acquired urinary tract infections in a prospective, controlled, double-blind comparison. (1992) (18)
Traveling toothpicks. (1983) (18)
Temporal Trends in Infective Endocarditis (2016) (18)
The role of fourth-generation cephalosporins in the treatment of serious infectious diseases in hospitalized patients. (1998) (17)
Impact of prior aspirin therapy on clinical manifestations of cardiovascular implantable electronic device infections. (2013) (17)
Ceftriaxone sodium therapy of penicillin G-susceptible streptococcal endocarditis. (1992) (17)
Treatment of streptomycin-susceptible enterococcal experimental endocarditis with combinations of penicillin and low- or high-dose streptomycin (1986) (17)
Pulmonary disease in the immunocompromised host. 1. (1985) (16)
Activity of penicillin combined with an aminoglycoside against group B streptococci in vitro and in experimental endocarditis. (1986) (16)
Prospective evaluation of the utility of molecular techniques for diagnosing nosocomial transmission of multidrug-resistant tuberculosis. (1996) (16)
Analysis of Pneumocystis carinii cysts with a fluorescence-activated cell sorter (1984) (15)
Beta-haemolytic streptococcal endocarditis: clinical presentation, management and outcomes (2016) (15)
Continuous intravenous versus intermittent ampicillin therapy of experimental endocarditis caused by aminoglycoside-resistant enterococci (1992) (15)
Antibiotic treatment of infective endocarditis. (1983) (15)
Invasive procedures in the diagnosis of pneumonia. (1988) (15)
Paranasal sinus mucormycosis in an immunologically competent host. (1985) (14)
Detection of viral and chlamydial antigens in open-lung biopsy specimens. (1985) (14)
Failure of time-kill synergy studies using subinhibitory antimicrobial concentrations to predict in vivo antagonism of cephalosporin-rifampin combinations against Staphylococcus aureus (1994) (14)
Efficacy of cilofungin therapy administered by continuous intravenous infusion for experimental disseminated candidiasis in rabbits (1992) (14)
Age- and Sex-Associated Trends in Bloodstream Infection (2015) (14)
Infective endocarditis--a changing spectrum. (1977) (14)
Utility of Brain Magnetic Resonance Imaging in the Surgical Management of Infective Endocarditis. (2017) (14)
Cardiovascular Implantable Electronic Device Infections due to Propionibacterium Species (2016) (13)
Prevalence of Helicobacter pylori in specific forms of gastritis. Further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. (1991) (13)
Pulmonary disease in the immunocompromised host (2). (2010) (13)
Is endocarditis prophylaxis for dental procedures necessary? (2017) (12)
Infective endocarditis following transcatheter aortic valve replacement: Diagnostic yield of echocardiography and associated echo-Doppler findings. (2018) (12)
Genitourinary Procedures as Risk Factors for Prosthetic Hip or Knee Infection: A Hospital-Based Prospective Case-Control Study (2015) (12)
Comparison of two methods used to prepare smears of mouse lung tissue for detection of Pneumocystis carinii (1982) (12)
Desulfovibrio legallii Prosthetic Shoulder Joint Infection and Review of Antimicrobial Susceptibility and Clinical Characteristics of Desulfovibrio Infections (2014) (12)
13 – Anaerobic Bacteremia and Cardiovascular Infections (1989) (12)
Effect of the American Heart Association 2007 Guidelines on the Practice of Dental Prophylaxis for the Prevention of Infective Endocarditis in Olmsted County, Minnesota (2017) (12)
Empiric therapy with moxalactam alone in patients with bacteremia. (1984) (12)
[14C]urea breath test for diagnosis ofHelicobacter pylori (1990) (11)
Efficacy and safety of gatifloxacin in elderly outpatients with community-acquired pneumonia. (2002) (11)
Variable Significance of Brain MRI Findings in Infective Endocarditis and Its Effect on Surgical Decisions. (2019) (11)
In vitro and in vivo studies of streptomycin-resistant, penicillin-susceptible streptococci from patients with infective endocarditis. (1987) (11)
Visceral leishmaniasis (kala-azar) as a cause of fever of unknown origin. (1980) (10)
Evaluation of new anti-infective drugs for the treatment of infective endocarditis. Infectious Diseases Society of America and the Food and Drug Administration. (1992) (10)
Antimicrobial agents in adult patients with renal insufficiency: initial dosage and general recommendations. (1987) (10)
Clinical, Radiographic, and Microbiologic Features of Infective Endocarditis in Patients With Hypertrophic Cardiomyopathy. (2017) (10)
Discriminative Ability and Reliability of Transesophageal Echocardiography in Characterizing Cases of Cardiac Device-Lead Vegetations versus Non-Infectious Echodensities. (2020) (9)
Association of Mitral Valve Prolapse With Infective Endocarditis Due to Viridans Group Streptococci. (2015) (9)
Temporal Trends of Infective Endocarditis in Olmsted County, Minnesota, Between 1970 and 2018: A Population-Based Analysis (2021) (9)
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. (2007) (9)
Antimicrobial therapy of streptococcal endocarditis. (1987) (8)
Endocarditis caused by B fragilis. (1983) (8)
Synergy of imipenem or penicillin G and aminoglycosides against enterococci isolated from patients with infective endocarditis (1984) (8)
Toxoplasmosis in patients with hematologic malignancies (2015) (8)
84 – Infections of Nonvalvular Cardiovascular Devices (2014) (8)
Clinical Presentation, Management, and Outcomes of Cardiovascular Implantable Electronic Device Infections Due to Gram-Negative Versus Gram-Positive Bacteria. (2019) (8)
Propensity score analysis with a time-dependent intervention is an acceptable although not an optimal analytical approach when treatment selection bias and survivor bias coexist. (2010) (8)
Prevalence ofHelicobacter pylori in specific forms of gastritis (1991) (7)
Shuttleworthia satelles endocarditis: evidence of non-dental human disease. (2010) (7)
Permanent Pacemaker and Implantable Cardioverter Defibrillator Infection (2017) (7)
Factors Predictive of Seizures Among Intensive Care Unit Patients with Gram‐Negative Infections (1990) (7)
Single-Dose Oral Amoxicillin or Linezolid for Prophylaxis of Experimental Endocarditis Due to Vancomycin-Susceptible and Vancomycin-Resistant Enterococcus faecalis (2007) (6)
Response to letter regarding article, "Incidence of infective endocarditis due to viridans group streptococci before and after publication of the 2007 American Heart Association's endocarditis prevention guidelines". (2013) (6)
Lack of extracellular slime effect on treatment outcome of Staphylococcus epidermidis experimental endocarditis. (1989) (6)
Effect of gentamicin dosing interval on efficacy of penicillin or ceftriaxone treatment of experimental endocarditis due to penicillin-susceptible, ceftriaxone-tolerant viridans group streptococci (1996) (6)
Diagnostic evaluation and management of culture‐negative cardiovascular implantable electronic device infections (2018) (6)
Cardiac valve replacement in patients with active infective endocarditis. (1983) (6)
Predictors of Bloodstream Infection in Patients Presenting With Cardiovascular Implantable Electronic Device Pocket Infection (2019) (6)
Haemophilus influenzae in respiratory tract infections in community-based clinical practice: therapy with gatifloxacin. (2002) (5)
Migratory Polyarthralgias and Skin Rash (2020) (5)
The use of cefotaxime for the treatment of common infections: in vitro, pharmacokinetic and clinical considerations. (1997) (5)
General Methodologies for Animal Models (1999) (5)
Tolerance and safety of orally administered antimicrobial agents: An important factor in the selection of drug therapy (1994) (5)
Antimicrobial agents in patients with renal insufficiency. (1977) (5)
Trovafloxacin Treatment of Viridans Group Streptococcus Experimental Endocarditis (2000) (5)
Recovery of Blastomyces dermatitidis from blood of a patient with disseminated blastomycosis (1987) (5)
Tetracyclines, chloramphenicol, erythromycin, and clindamycin. (1987) (4)
Young, American Heart Association Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Statement for Health Professionals From the Committee on Rheumatic Fever, Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A (2004) (4)
Animal models as predictors of outcome of therapy with broad spectrum cephalosporins. (1992) (4)
Antimicrobial agents in patients with renal insufficiency. (1977) (4)
Risk of late endocarditis following congenital heart repair: 30 year follow-up in 610 patients (1991) (4)
P1-57: Pacemaker and ICD infections: Risk factor analysis using a case-control study (2006) (3)
Prophylaxis and treatment of infections complicating abdominal surgery. (1992) (3)
Rapid Appraisal System for COVID-19 Medical Information (2020) (3)
End-of-Therapy Echocardiography May Not Be Needed in All in Patients With Endocarditis (2020) (3)
Management of infection in total knee replacement. (1988) (3)
The Public Health Impact of Delaying a Second Dose of the BNT162b2 or mRNA-1273 COVID-19 Vaccine (2021) (3)
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats. Task Force III: prevention and control of cardiovascular complications of emerging infectious diseases and potential biological terrorism agents and diseases. (2007) (3)
Antibiotic prophylaxis for bacterial endocarditis: an evolving story with new paradigms. (1997) (3)
Disease , Council on Cardiovascular Disease in the Young , American Heart for Health Professionals From the Committee on Rheumatic Fever , Endocarditis and Diagnosis , Treatment , and Long-Term Management of Kawasaki Disease : A Statement (2004) (3)
Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research (2021) (2)
Diagnosis, Management, and Outcomes of Brain Abscess due to Gram-Negative Versus Gram-Positive Bacteria: Brain abscess due to Gram-positive vs. Gram-negative bacteria. (2021) (2)
Infections associated with implantable cardioverter defibrillators--still more questions. (1998) (2)
Erratum to: Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections (2012) (2)
Erratum: Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections (Journal of Interventional Cardiac Electrophysiology (2011) 31:2 (171-183) DOI: 10.1007/s10840-010-9537-x) (2012) (2)
Impacts of a care process model and inpatient electrophysiology service on cardiovascular implantable electronic device infections: a preliminary evaluation (2017) (2)
Reply to Eisen and Denholm, Dauchy et al, Fierer, and Nguyen and Jones. (2013) (2)
A Contemporary Population-Based Profile of Infective Endocarditis Using the Expanded Rochester Epidemiology Project. (2021) (2)
Euthermic Endocarditis (2013) (2)
Tetracyclines, chloramphenicol, erythromycin, and clindamycin. (1983) (2)
Antibiotic Prophylaxis for Bacterial Endocarditis: An Evolving Story With New Paradigms (1997) (2)
Evaluation of antibiotic therapy following valve replacement for native valve endocarditis (2009) (2)
Synergy ofImipenem orPenicillin G andAminoglycosides Against Enterococci Isolated fromPatients withInfective Endocarditis (1984) (1)
Independent Association? : A Scientific Statement From the American Heart Association Periodontal Disease and Atherosclerotic Vascular Disease: Does the Evidence Support an (2012) (1)
Infectious Diseases Society of America position statement on the role of hospital pharmacists. (1998) (1)
Dosage of vancomycin. (1978) (1)
Overview and risk factors for postcraniotomy surgical site infection: A four-year experience (2022) (1)
Treatment of infections caused by anaerobes. (1991) (1)
Recognition and treatment of infective endocarditis. (1992) (1)
Adapted from: Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement From the American Heart Association. (2021) (1)
Failure to recover Chlamydia trachomatis from open-lung biopsy tissue of adult immunosuppressed patients. (1984) (1)
IMPACT OF THE AMERICAN HEART ASSOCIATION’S 2007 GUIDELINES ON THE PRACTICE OF DENTAL PROPHYLAXIS FOR THE PREVENTION OF INFECTIVE ENDOCARDITIS IN HIGH RISK PATIENTS: OLMSTED COUNTY, MINNESOTA (2016) (1)
ACCF/AHA/CDC Conference report on emerging infectious diseases and biological terrorism threats. Task Force III: prevention and control of cardiovascular complications of emerging infectious diseases and potential biological terrorism agents and diseases. (2007) (1)
Comment on: The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials. (2006) (1)
Diagnosis andTherapy of Kawasaki Disease inChildren (1993) (1)
Prospective Determination of Bacteremia and Associated Complications in Patients Undergoing Endoscopic Ultrasound Guided Fine Needle Aspiration (EUS FNA) of Rectal and Perirectal Lesions (2006) (1)
[Infectious endocarditis: perspectives toward 2000]. (1995) (1)
Author response: Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis (2020) (1)
Vertebral osteomyelitis due to Shigella boydii. (1996) (1)
1074. Management and Outcomes of Infective Endocarditis Due to Nutritionally Variant Streptococci (2018) (1)
Selection of cephalosporins for hospital formularies. (1995) (1)
Infective Endocarditis Due to Neisseria elongata (2010) (1)
Noninvasive detection of cardiac abscesses complicating infective endocarditis (1987) (1)
Serodiagnosis ofHelicobacter pylori: Comparison ofEnzyme- Linked Immunosorbent Assays (1991) (0)
Antimicrobial Therapy ofExperimental Endocarditis Causedby Nutritionally Variant Viridans GroupStreptococci (1986) (0)
Synergy ofPenicillin andDecreasing Concentrations of Aminoglycosides Against Enterococci fromPatients with Infective Endocarditis (1980) (0)
Predictors of Treatment Failure in Patients With Pyogenic Brain Abscess (2022) (0)
83 – Prosthetic Valve Endocarditis (2015) (0)
Cardiac infections (1989) (0)
The Clinical Use of Penicillin—Revisited (1992) (0)
Treatment of beta lactamase positive blp haemophilus influenzae type b hib experimental pneumonia in mice (1990) (0)
Ciprofloxacin Therapy ofExperimental Endocarditis Caused byMethicillin-Susc eptible (1988) (0)
In conclusion, S. boydii should be considered among the rare but possible causes of vertebral osteomyelitis. (1996) (0)
P04 PREVALENCE OF ENDOCARDITIS AMONG PATIENTS WITH PROSTHETIC HEART VALVES AND STAPHYLOCOCCUS AUREUS BACTEREMIA (2013) (0)
Distant infection and the risk of Prosthetic Joint Infection (PJI): A case control study (2010) (0)
Impact of a Care Process Model on Management of Cardiovascular Implantable Electronic Device Infections (2016) (0)
Beta Hemolytic Streptococcus Infective Endocarditis: Factors Associated with Early Mortality (2015) (0)
PREDICTING RISK OF INFECTIVE ENDOCARDITIS AT THE TIME OF FIRST REPORTED POSITIVE BLOOD CULTURE WITH STAPHYLOCOCCUS AUREUS (2014) (0)
Antibiotic Treatment for Infective Endocarditis-Reply (1996) (0)
Infective endocarditis: experimental and clinical developments (1987) (0)
Influence ofGentamicin DoseSize ontheEfficacies of Combinations ofGentamicin andPenicillin inExperimental Streptomycin-Resistant (1982) (0)
TEMPORAL TRENDS OF INFECTIVE ENDOCARDITIS EPIDEMIOLOGY FROM 2007-2013 IN OLMSTED COUNTY, MINNESOTA (2015) (0)
The Public Health Impact of Delaying a Second Dose of the BNT162b2 or mRNA-1273 COVID-19 Vaccine Authors: (2021) (0)
Microbiological andClinical Evaluation oftheIsolator Lysis- Centrifugation BloodCulture Tube (1983) (0)
LackofInVivoandInVitro Bactericidal Activity ofN- Formimidoyl Thienamycin Against Enterococci (1982) (0)
Transesophageal echocardiography and bacterial endocarditis. (1993) (0)
Abstract 15979: Utility of Post-extraction Follow-up Blood Cultures in Patients With Cardiovascular Implantable Electronic Device Infection (2020) (0)
Abstract 2490: Cardiovascular Implantable Electronic Device Infection in Patients With Non-Staphylococcus aureus Gram-Positive Coccal Bacteremia (2009) (0)
Abstract 14431: Low Prevalence of Bacterial Colonization of Electively Explanted Cardiovascular Implantable Electronic Devices (CIEDs) (2012) (0)
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. (2007) (0)
Antimicrobial chemoprophylaxis. (1983) (0)
and the Quality of Care and Cardiovascular Disease in the Young, the on Clinical Cardiology, Endocarditis, and on Association. A Guideline From the American Heart Association Rheumatic Prevention of Infective Endocarditis. Guidelines From the American Heart (2007) (0)
Antimicrobial Agents: Dr. Wilson replies (1988) (0)
Serodiagnosis of Helicobacter pylori: Comparison of Enzyme- (0)
Abstract 8416: Clinical Predictors of Short- and Long-Term Mortality Among Patients with Cardiovascular Implantable Electronic Device Infection (2011) (0)
UTILITY OF CARDIAC COMPUTED TOMOGRAPHY SCANNING IN THE DIAGNOSIS AND PREOPERATIVE EVALUATION OF PATIENTS WITH INFECTIVE ENDOCARDITIS (2017) (0)
Relative Efficacies ofBroad-Spectrum Cephalosporins forTreatment ofMethicillin-Susc eptible Staphylococcus aureusExperimental Infective Endocarditis (1993) (0)
Cardiac Implantable Electronic Device Infection due to Propionibacterium Species (2015) (0)
Abstract 13134: Impact of the American Heart Association’s 2007 Guidelines on the Practice of Dental Prophylaxis for the Prevention of Infective Endocarditis in Olmsted County, Minnesota (2015) (0)
A rare case of infective endocarditis in a quadricuspid aortic valve caused by Gemella sanguinis (2021) (0)
Abstract 20081: Predicting Risk of Endovascular Device Infection in Patients with Staphylococcus aureus Bacteremia (2014) (0)
26-year-old man with HIV infection and abdominal pain. (1995) (0)
Presence of a central venous catheter is associated with a markedly increased risk of permanent pacemaker infection (2013) (0)
004 RECENT TRENDS IN THE EPIDEMIOLOGY OF INFECTIVE ENDOCARDITIS: A POPULATION-BASED STUDY IN OLMSTED COUNTY, MINNESOTA (2009) (0)
Infective endocarditis: experimental and clinical developments, antimicrobial therapy and management of complications (1988) (0)
Ciprofloxacin Therapy ofExperimental Endocarditis Causedby Methicillin-Resi stant Staphylococcus epidermidis (1990) (0)
Reference to index of the correspondence, letterbooks, workdiaries and notebooks, specifications, photographs and sketches of John Wilson and Sons, boatbuilders, Cygnet (2010) (0)
P1483 Permanent pacemaker and implantable cardioverter-defibrillator-related infective endocarditis (2007) (0)
Repeat transesophageal echocardiography in infective endocarditis: An analysis of contemporary utilization (2020) (0)
[Infectious endocarditis caused by Gram-negative bacteria]. (1989) (0)
Are Gastrointestinal Endoscopic Procedures Associated with an Increased Risk of Prosthetic Joint Infection (PJI)?: 1387 (2009) (0)
Infective endocarditis (1989) (0)
Endocarditis Prevention 2006: Potential Implications of the New AHA Guidelines (2006) (0)
Impact of a Primary Inpatient Electrophysiology Service on Cardiovascular Implantable Electronic Device Infections in a Tertiary Care Hospital (2016) (0)
Analysis ofPneumocystis carinii Cystswitha Fluorescence- Activated CellSorter (1984) (0)
P29 EFFECT ON HOSPITAL LENGTH OF STAY FOR CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE INFECTIONS FOLLOWING IMPLEMENTATION OF AN EVIDENCE-BASED TREATMENT ALGORITHM (2013) (0)
Comment on: The role of aminoglycosides in combination with a β-lactam for the treatment of bacterial endocarditis : a meta-analysis of comparative trials. Authors' reply (2006) (0)
924Clinical Decision Rule to Guide Use of Echocardiography in the Management of Staphylococcus aureus Bacteremia (2014) (0)
Therapy for Enterococcus faecalis Infective Endocarditis in the Era of A Dual Beta-Lactam Regimen: An Institutional Experience 2008–2015 (2016) (0)
Rationale for Changes in Recommendations for Antibiotic Prophylaxis for Endocarditis (2007) (0)
ANTIBIOTIC TREATMENT FOR INFECTIVE ENDOCARDITIS. AUTHORS' REPLY (1996) (0)
Five-Year Mortality of Native Versus Prosthetic Valve Endocarditis in a Population-Based Cohort (2015) (0)
FIVE-YEAR MORTALITY OF INFECTIVE ENDOCARDITIS IN A POPULATION-BASED COHORT (2016) (0)
924Clinical Decision Rule to Guide Use of Echocardiography in the Management of Bacteremia. (2014) (0)
Comparison ofTwoMethodsUsedtoPrepare Smearsof MouseLungTissue forDetection ofPneumocystis carinii (1982) (0)
Current therapeutic problems and management of respiratory tract infections : proceedings of a symposium held on June 29, 1993, at the 18th International Congress of Chemotherapy, Stockholm, Sweden (1994) (0)
[New strategies in the treatment of infectious endocarditis]. (1995) (0)
Comparative in vitro activity of the new Penem CGP 31608 (1987) (0)
IMPACT OF DEVICE FEATURES AND HOST CHARACTERISTICS ON RISK OF PACEMAKER INFECTION (2013) (0)
INFECTIVE ENDOCARDITIS FOLLOWING TRANSCUTANEOUS AORTIC VALVE IMPLANTATION: CLINICAL, ECHOCARDIOGRAPHIC AND HEMODYNAMIC FEATURES (2017) (0)
VALIDATION OF CLINICAL CRITERIA SET TO GUIDE TRANSESOPHAGEAL ECHOCARDIOGRAPHY IN THE MANAGEMENT OF PATIENTS WITH STAPHYLOCOCCUS AUREUS BACTEREMIA (2013) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Walter R. Wilson?

Walter R. Wilson is affiliated with the following schools:

Mayo Clinic College of Medicine and Science

Walter R. Wilson's Academic­Influence.com Rankings

Walter R. Wilson's Degrees

Why Is Walter R. Wilson Influential?

Walter R. Wilson's Published Works

Published Works

What Schools Are Affiliated With Walter R. Wilson?

Walter R. Wilson's AcademicInfluence.com Rankings